Post-approval studies (Phase 4)Study completedNCT00317902
What this trial is testing
An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)
Who this might be right for
AnemiaHIV Infections
Ortho Biotech Products, L.P. 292